Intellipharmaceutics International Inc. (IPCIF)
Data as of September 4, 2026 · Biotechnology
Stockbruh grade: Challenging 0/5 metrics rated Sunny
What does Intellipharmaceutics International Inc. do?
Intellipharmaceutics International Inc., a cool pharmaceutical company based in Toronto 🍁, develops funky and innovative controlled-release drugs in various therapeutic areas like neurology and cardiovascular. They offer products like Focalin XR for hyperactivity, Protonix for heartburn, and Seroquel XR for mental health. They're even working on a cool pain reliever called OxyContin! 💊🌟⚡️.
Key Numbers
| Metric | Rating | What it means |
|---|
| Returns (5Y) | ⛈️ Weak | 5-year price performance |
| Profitability | ⛈️ Weak | Net margin & return on equity |
| Growth | ⛅ Moderate | Revenue & earnings trend |
| Earnings | ⛈️ Weak | EPS vs analyst expectations |
| Cash & Debt | ⛈️ Weak | Balance sheet strength |
| Price | $0.15 | Market Cap | — |
| Exchange | Other OTC | | |
Plain-English Analysis
What's it worth?
Returns have been below average recently — worth reviewing valuation carefully before investing. Sign up free to see the full Stockbruh valuation breakdown.
How the business works
Intellipharmaceutics International Inc., a cool pharmaceutical company based in Toronto 🍁, develops funky and innovative controlled-release drugs in various therapeutic areas like neurology and cardiovascular. They offer products like Focalin XR for hyperactivity, Protonix for heartburn, and Seroquel XR for mental health. Sign up free for competitor and revenue breakdown ↗
Are they building the future?
Growth is mixed — some positive signals, but not consistent. Sign up free for Stockbruh's full growth breakdown.
What's ahead?
Recent earnings have disappointed — missing expectations or reporting losses. Sign up free to see the full earnings analysis and what's driving the weakness.